美邦股份(605033) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 312,087,364.29, representing a decrease of 9.46% compared to the same period last year[5] - Net profit attributable to shareholders was CNY 44,438,201.38, down 35.85% year-on-year[5] - The net profit after deducting non-recurring gains and losses was CNY 38,394,463.08, a decline of 43.58% compared to the previous year[5] - Basic earnings per share decreased to CNY 0.33, down 35.85% from the same period last year[5] - Net profit for Q1 2024 was CNY 44,438,201.38, down 35.7% from CNY 69,276,052.01 in Q1 2023[21] - Operating profit decreased to CNY 49,551,153.96 in Q1 2024 from CNY 79,271,153.70 in Q1 2023, a decline of 37.5%[21] - The weighted average return on net assets was 3.91%, a decrease of 2.27 percentage points compared to the previous year[5] Cash Flow and Liquidity - The net cash flow from operating activities was negative CNY 21,649,662.18, an increase in outflow of 65.60% year-on-year[5] - The net cash flow from operating activities was negative CNY 21,649,662.18 in Q1 2024, an improvement from negative CNY 62,936,566.19 in Q1 2023[24] - Cash received from investment recoveries was CNY 392,000,000.00 in Q1 2024, compared to CNY 365,000,000.00 in Q1 2023, an increase of 7.4%[24] - Total cash inflow from investment activities was CNY 393,671,078.58, compared to CNY 366,600,046.75 in the previous period, reflecting an increase of approximately 7.3%[25] - Cash outflow from investment activities totaled CNY 627,316,929.48, up from CNY 369,193,751.59, indicating a significant increase of about 69.9%[25] - Net cash flow from investment activities was negative CNY 233,645,850.90, compared to a negative CNY 2,593,704.84 in the previous period, showing a decline in cash flow[25] - Total cash inflow from financing activities was CNY 2,393,700.00, down from CNY 22,081,558.23, representing a decrease of approximately 89.2%[25] - Net cash flow from financing activities was negative CNY 12,551,195.84, contrasting with a positive CNY 14,581,558.23 in the previous period, indicating a significant shift[25] - The net increase in cash and cash equivalents was negative CNY 267,846,708.92, compared to a negative CNY 50,948,712.80 in the previous period, reflecting a worsening cash position[25] - The ending balance of cash and cash equivalents was CNY 184,583,918.19, down from CNY 242,286,396.44, showing a decrease of approximately 23.8%[25] - The company did not receive any cash from new investments or borrowings during the quarter, indicating a potential liquidity challenge[25] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,679,567,857.33, a decrease of 0.73% from the end of the previous year[6] - Total assets decreased from ¥1,692,002,297.54 to ¥1,679,567,857.33, a decline of about 0.74%[17] - Current liabilities decreased from ¥460,905,616.99 to ¥340,726,496.75, a reduction of approximately 26%[17] - Total liabilities decreased to CNY 520,963,938.96 in Q1 2024 from CNY 577,836,580.55 in Q1 2023, a decline of 9.8%[21] - Total non-current assets increased from ¥620,209,388.00 to ¥647,229,245.97, an increase of approximately 4.5%[17] Shareholder Information - Shareholders' equity attributable to the parent company increased to CNY 1,158,603,918.37, up 3.99% year-on-year[6] - Total equity increased to CNY 1,158,603,918.37 in Q1 2024 from CNY 1,114,165,716.99 in Q1 2023, an increase of 4.0%[21] - The largest shareholder, Zhang Shaowu, holds 59,100,000 shares, representing 43.71% of the total shares[12] - The total number of ordinary shares at the end of the reporting period was 8,407[12] Investment and Development - The company reported a significant increase in investment income by 75.42%, attributed to higher investment returns[8] - The company experienced a 247.05% increase in asset impairment losses, primarily due to increased provisions for inventory depreciation[8] - The company reported a significant increase in prepayments from ¥26,943,735.86 to ¥42,652,617.33, an increase of about 58%[16] - The significant increase in investment payments to CNY 578,000,000.00 from CNY 345,000,000.00 suggests a strategic focus on expanding long-term assets[25] - The company has not reported any new product developments or market expansion strategies in the current quarter[15] - The company has not adopted new accounting standards or interpretations for the current year, maintaining consistency in financial reporting[25] Research and Development - Research and development expenses decreased to CNY 17,030,924.26 in Q1 2024 from CNY 19,925,881.93 in Q1 2023, a reduction of 14.5%[21]